Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-05

Clinical Trial Update: Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on autologous dendritic cell therapy as adjunct treatment for diabetic kidney disease; Phase 1/Phase 2, currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous dendritic cell therapy (dendritic cells (autologous))

Snippet

Sponsor: PT. JES Kasih Nusantara Sejahterah | Conditions: Diabetic Kidney Disease (DKD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING